TScan Therapeutics, Inc.
NASDAQ:TCRXBiotechnology
Healthcare
$0.82 +2.23%
+$0.02 today
- Market cap
- $50.37M
- Beta
- 1.03
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$0.96
52W Low $0.85High $2.57
Volume 0.00M
Average 0.81M
Price history
TScan Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-19.93%
Period high
$1.43
Period low
$0.82
Latest
$0.82
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| 8-K | May 22, 2026 | May 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| 4 | May 22, 2026 | May 22, 2026 | |
| SC 13G/A | May 15, 2026 | May 15, 2026 | |
| 10-Q | May 6, 2026 | May 6, 2026 | |
| 8-K | May 6, 2026 | May 6, 2026 | |
| ARS | Apr 17, 2026 | Apr 17, 2026 | |
| DEF 14A | Apr 17, 2026 | Apr 17, 2026 | |
| PRE 14A | Apr 7, 2026 | Apr 7, 2026 | |
| 8-K | Apr 2, 2026 | Apr 2, 2026 |
Competitors
Who does TScan Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about TCRX's filings, answered from its disclosures.
What is the latest TCRX filing?
The latest filing shown is 8-K dated Jun 22, 2026.
How many recent filings does TCRX have?
Intrinsic Alpha currently shows 20 recent filings for TCRX.
Continue the stock analysis
Jump to another research area for this company.